# About Prime Peptide Labs — An Independent Recovery-Research Desk

> About Prime Peptide Labs: an independent literature digest on three Recovery & Tissue Repair research peptides. How it is compiled, and what it is not — not a seller, not a clinic, not medical advice.

An independent, citation-anchored digest of the recovery-peptide literature. Not a vendor. Not a clinic. Not medical advice.

## What Prime Peptide Labs is

Prime Peptide Labs is an independent editorial reading desk covering the published research on three peptides studied for **recovery and tissue repair**: GHK-Cu, TB-500, and BPC-157, with GHK-Cu as the lead. The site exists to make a scattered, uneven, and frequently overstated literature legible — to tell a reader, in plain language and with citations, what each compound was actually studied for, in which species, and how far that evidence really reaches.

The organizing idea is the three-sided repair picture: a copper-carrying matrix-builder (GHK-Cu), an actin-regulating cell migrator (TB-500), and an angiogenesis-forward tissue protector (BPC-157). Reading them together gives a fuller picture of how the body's repair machinery works — and where these compounds do and do not fit — than any one of them alone. Each compound has its own page, a comparison page lines them up side by side, and a single shared references list aggregates every source.

## How it is compiled

Three principles govern what appears here.

*First, everything is anchored to the peer-reviewed literature.* Every research claim is tied to a numbered citation — PubMed-indexed journal articles and reviews, with DOIs and PubMed or PubMed Central links — collected on the [references page](/references). Where a finding comes from a review rather than a primary study, the review is cited as such.

*Second, the evidence is reported at its actual strength.* Doses are described in the species and route in which they were studied — for example, "studied at 2 mg/kg in Wistar rats" — never scaled to humans or offered as a recommendation. Where evidence is preclinical, single-lab, or rests on a parent molecule rather than the marketed compound, the page says so plainly. That candor about limits is the point of the desk, not an afterthought.

*Third, the three pages are cross-referenced.* Because the same themes — angiogenesis, actin and migration, collagen synthesis — recur across compounds, the pages link to one another so a reader can follow a mechanism from one peptide to the next.

## What it is not

Prime Peptide Labs is not a store, not a clinic, and not a source of medical advice. It does not sell, supply, source, or broker any peptide or research chemical, and it has no affiliate or referral relationship with any vendor. It does not employ clinicians, diagnose conditions, or prescribe anything. It does not recommend a dose, schedule, or route of administration for any person, and it never frames an animal-study dose as something a human should take.

The peptides discussed here are research compounds. None is an approved medicine for systemic human use; two of the three are explicitly prohibited in sport. Readers with questions about any condition described in the underlying research should consult a licensed clinician in their own jurisdiction, working with regulated, evidence-based options. What this site offers is a calm, accurate map of the published literature — nothing more, and nothing it pretends to be.

---

A plain-language reading desk for recovery-peptide research — citations on every claim, no products, no prescriptions.